» Articles » PMID: 39548081

Amantadine Against Glioma Via ROS-mediated Apoptosis and Autophagy Arrest

Overview
Journal Cell Death Dis
Date 2024 Nov 15
PMID 39548081
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma is a common primary nervous system malignant tumor with poor overall cure rate and low survival rate, yet successful treatment still remains a challenge. Here, we demonstrated that amantadine (AMT) exhibits the powerful anti-glioma effect by promoting apoptosis and autophagy in vivo and in vitro. Mechanistically, amantadine induces a large amount of reactive oxygen species (ROS) accumulation in glioma cells, and then triggers apoptosis by destroying mitochondria. In addition, amantadine induces the initiation of autophagy and inhibits the fusion of autophagosome and lysosome, consequently performing an anti-glioma role. Taken together, our findings suggest that amantadine could be a promising anti-glioma drug that inhibits glioma cells by inducing apoptosis and autophagy, which may provide a novel potential treatment option for patients.

Citing Articles

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities.

Zhang J, Zhang J, Yang C J Transl Med. 2025; 23(1):52.

PMID: 39806481 PMC: 11727735. DOI: 10.1186/s12967-024-06063-0.

References
1.
Singh S, Vats S, Chia A, Tan T, Deng S, Ong M . Dual role of autophagy in hallmarks of cancer. Oncogene. 2017; 37(9):1142-1158. DOI: 10.1038/s41388-017-0046-6. View

2.
Srinivas U, Tan B, Vellayappan B, Jeyasekharan A . ROS and the DNA damage response in cancer. Redox Biol. 2019; 25:101084. PMC: 6859528. DOI: 10.1016/j.redox.2018.101084. View

3.
Vogl D, Stadtmauer E, Tan K, Heitjan D, Davis L, Pontiggia L . Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy. 2014; 10(8):1380-90. PMC: 4203515. DOI: 10.4161/auto.29264. View

4.
Pushpakom S, Iorio F, Eyers P, Jane Escott K, Hopper S, Wells A . Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018; 18(1):41-58. DOI: 10.1038/nrd.2018.168. View

5.
Milano M, Johnson M, Sul J, Mohile N, Korones D, Okunieff P . Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol. 2009; 98(1):83-92. DOI: 10.1007/s11060-009-0054-7. View